AVLSA

Atlas Venture Life Science Advisors Portfolio holdings

AUM $662M
This Quarter Return
+1.09%
1 Year Return
+6.63%
3 Year Return
+286.7%
5 Year Return
–
10 Year Return
–
AUM
$950M
AUM Growth
+$950M
Cap. Flow
-$61.6M
Cap. Flow %
-6.49%
Top 10 Hldgs %
97.71%
Holding
16
New
–
Increased
2
Reduced
5
Closed
1

Top Buys

1
IRON icon
Disc Medicine
IRON
$10M
2
KRRO icon
Korro Bio
KRRO
$605K

Top Sells

1
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
$68.6M
2
DNTH icon
Dianthus Therapeutics
DNTH
$1.29M
3
XLO icon
Xilio Therapeutics
XLO
$1.07M
4
KYMR icon
Kymera Therapeutics
KYMR
$804K
5
JBIO
Jade Biosciences, Inc. Common Stock
JBIO
$398K

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
DYN icon
1
Dyne Therapeutics
DYN
$1.87B
$283M 29.8%
8,020,136
– –
KYMR icon
2
Kymera Therapeutics
KYMR
$2.86B
$160M 16.82%
5,350,422
-26,940
-0.5% -$804K
THRD
3
DELISTED
Third Harmonic Bio
THRD
$142M 14.93%
10,907,859
– –
IRON icon
4
Disc Medicine
IRON
$2.08B
$113M 11.91%
2,509,456
+222,223
+10% +$10M
DAWN icon
5
Day One Biopharmaceuticals
DAWN
$760M
$88.6M 9.33%
6,430,257
– –
KRRO icon
6
Korro Bio
KRRO
$198M
$38.5M 4.06%
1,137,149
+17,857
+2% +$605K
QTTB icon
7
Q32 Bio
QTTB
$20.6M
$37.6M 3.95%
2,092,106
– –
GBIO icon
8
Generation Bio
GBIO
$39.9M
$23.3M 2.46%
8,279,484
– –
VIGL
9
DELISTED
Vigil Neuroscience
VIGL
$23.3M 2.46%
5,836,874
– –
REPL icon
10
Replimune Group
REPL
$446M
$18.9M 1.99%
2,098,300
– –
IMA
11
ImageneBio, Inc. Common Stock
IMA
$149M
$8.28M 0.87%
5,018,178
– –
TECX
12
Tectonic Therapeutic, Inc. Common Stock
TECX
$327M
$6.23M 0.66%
378,447
-4,162,934
-92% -$68.6M
DNTH icon
13
Dianthus Therapeutics
DNTH
$776M
$3.55M 0.37%
136,979
-50,000
-27% -$1.29M
JBIO
14
Jade Biosciences, Inc. Common Stock
JBIO
$259M
$2.99M 0.31%
1,799,232
-240,017
-12% -$398K
SPRO icon
15
Spero Therapeutics
SPRO
$115M
$696K 0.07%
535,336
-72,277
-12% -$94K
XLO icon
16
Xilio Therapeutics
XLO
$36.1M
– –
-992,912
Closed -$1.07M